|11th November 2020||Richard J Berman||20,000||Open or private sale||$55.55||$1,110,934.00|
|11th November 2020||Richard J Berman||11,700||Exercise of derivative||$4.56||$53,352.00|
|11th November 2020||Richard J Berman||8,300||Exercise of derivative||$3.07||$25,481.00|
|30th September 2020||Edward J Zecchini||192||Grant/award etc.||$47.82||$9,181.44|
|30th September 2020||Daniel M Hancock||240||Grant/award etc.||$47.82||$11,476.80|
|29th July 2020||Richard J Berman||8,138||Exercise of in-the-money or at-the-money derivatives securities (usually options)||$3.57||$29,052.66|
|20th July 2020||Robert J Hariri||15,300||Exercise of in-the-money or at-the-money derivatives securities (usually options)||$3.57||$54,621.00|
|30th June 2020||Edward J Zecchini||310||Grant/award etc.||$29.54||$9,157.40|
|30th June 2020||Daniel M Hancock||389||Grant/award etc.||$29.54||$11,491.06|
|28th May 2020||Richard J Berman||1,112||Exercise of in-the-money or at-the-money derivatives securities (usually options)||$6.00||$6,672.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.